SEATTLE, WA (PRWEB) March 05, 2021 Intelligent.com, a trusted resource for online degree rankings and higher education planning, has announced the Top 50
The Interfaith Alliance of Oklahoma will host a virtual discussion about mental health in the coming days. A "Discussion Panel regarding Mental Health and Marginalized Communities" is set for 7 p.m…
By Staff Report
The City Sentinel, Staff Report OKLAHOMA CITY Members of the Oklahoma House Democratic Caucus and the Oklahoma Legislative Black Caucus recognized the Norman High School girl’s basketball team on the.
AUSTIN, Texas /Massachusetts Newswire – National News/ Caisson Biotech and parent company Heparinex are pleased to announce that they have received a positive examination report from the European Patent Office for a patent covering the chemoenzymatic production of heparosan utilized in the HEPtune® drug delivery platform. Once certified, the new patent family will increase patent coverage across Europe, adding to the U.S. holdings.
The HEPtune platform, which utilizes heparosan, a naturally occurring polysaccharide, has been validated as a novel half-life extension and drug delivery alternative to commonly used polyethylene glycol (PEG). Unlike PEG, heparosan is naturally found in humans, is completely biodegradable, and will not trigger anaphylactic shock or anti-drug antibodies. The HEPtune platform has been applied to numerous drug classes including biologics, and small molecules via nanocarriers, including liposomes.
Tower Theatre to host Free COVID-19 Testing Event on March 1 city-sentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from city-sentinel.com Daily Mail and Mail on Sunday newspapers.